Business Context and Reporting Period
This Form 6-K filing by The GrowHub Limited (Growhub) covers the month of August 2026. The report primarily addresses the Company's ongoing efforts to maintain its listing on The Nasdaq Capital Market following notifications of non-compliance with minimum bid price and stockholders' equity requirements.
Key Financial Metrics
The filing does not provide current revenue, profit, cash flow, or margin data for the reporting period. The only specific financial figure disclosed relates to historical equity:
- Stockholders' Equity: $2,299,129 (as reported in the Form 20-F for the period ended December 31, 2025). This amount was below the $2,500,000 minimum required for continued listing.
Other financial metrics such as debt, liquidity, and operating results are not detailed in this document.
Material Changes and Corporate Actions
The filing details significant developments regarding the Company's listing status and a proposed merger:
- Nasdaq Delisting Determination: On June 5, 2026, Nasdaq determined to delist the Company due to failure to meet minimum bid price and stockholders' equity standards.
- Appeal Outcome: Following a hearing on July 16, 2026, the Nasdaq Hearings Panel granted an exception on July 29, 2026, allowing the Company to continue listing subject to conditions.
- Proposed Merger: On July 14, 2026, the Company entered into a Merger Agreement with EnChem Co., Ltd. and its subsidiary, EnChem America, Inc. The transaction involves a reverse merger structure where the Target will become a wholly-owned subsidiary of Growhub.
- Ownership Change: Upon closing, Target shareholders will receive shares constituting 85% of the Company's fully-diluted shares, triggering a change in control and requiring compliance with Nasdaq's initial listing standards.
Guidance, Outlook, and Risks
Compliance Timeline: The Company must demonstrate compliance with Nasdaq's initial listing rules on or prior to December 2, 2026.
Management Commentary: Management is working to close the Merger within the exception period. However, the filing explicitly states there is no assurance the Merger will be completed by the deadline or at all.
Risks and Contingencies:
- Failure to satisfy closing conditions of the Merger Agreement.
- Failure to regain compliance with Nasdaq requirements by December 2, 2026, which could result in delisting.
- The Panel reserves the right to reconsider the exception based on significant events.
- Forward-looking statements regarding the transaction are subject to significant uncertainties.
Investor Verification Checklist
- Verify the current status of the Merger Agreement with EnChem America, Inc. and whether closing conditions are being met.
- Confirm the Company's ability to meet Nasdaq's initial listing standards by the December 2, 2026 deadline.
- Review the most recent Form 20-F for detailed financial statements, as this 6-K contains no current operating data.
- Monitor for any further communications from Nasdaq regarding the exception terms or potential reconsideration of the listing status.